UM Ventures News
Profectus BioSciences Initiates Ebola Vaccine Phase 1 Clinical Trial
Tuesday, January 19, 2016
Harpoon Medical could sell to new investor, Edwards Lifesciences
Tuesday, December 15, 2015
PaxVax, Inc. Announces $105 Million Investment from Cerberus Capital Management
Wednesday, December 9, 2015
Remedy Pharmaceuticals Completes $9 Million Financing
Tuesday, December 1, 2015
School of Medicine Researchers Work to Develop GammaPod for Breast Cancer Therapy
Tuesday, November 24, 2015
Profectus Preclinical Data of Multi-Component Vaccine Provides Protection Against Ebola & Marburg Virus
Thursday, November 19, 2015
MedImmune Forms New Research Initiative with UM School of Pharmacy's Dr. Bruce Yu
Tuesday, November 3, 2015